Venous Thromboembolism Risk in Patients With Newly Diagnosed Multiple Myeloma Treated with Carfilzomib or Bortezomib in Combination With Lenalidomide and Dexamethasone
Titel:
Venous Thromboembolism Risk in Patients With Newly Diagnosed Multiple Myeloma Treated with Carfilzomib or Bortezomib in Combination With Lenalidomide and Dexamethasone
Auteur:
Loncharich, Alexa J. Fiala, Mark A. Slade, Michael J. Vickroy, Angela Kavanaugh, Margaret Wilson, Carmen Schroeder, Mark A. Stockerl-Goldstein, Keith Vij, Ravi Sanfilippo, Kristen M.